Skip to content
Recall Observatory FDA recall evidence

Drug product

Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC 63323-487-07, Tray NDC 63323-487-37

D-0651-2021

June 25, 2021

Class II

Product summary

Firm
Fresenius Kabi USA LLC
Event
Event 88194
Status
Terminated
Classification
Class II
Quantity
234,800 vials
Official record key
drug-enforcement:D-0651-2021

Official wording

Reason: Low out of specification results for epinephrine assay.

Code information: Batch, expiry: Batch 6123435, exp 01/2022; 6124730, 6124731, exp 07/2022

Distribution pattern: Distributed Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification